Prescription drug

Procaps Group to Report First Quarter 2021 Financial Results on May 13, 2021 After the Market Close

Retrieved on: 
Tuesday, May 11, 2021

Procaps Group expects full-year Adjusted EBITDA margin expansion from 22% in 2019 to 26% in 2021 with strong positive free cash flow.

Key Points: 
  • Procaps Group expects full-year Adjusted EBITDA margin expansion from 22% in 2019 to 26% in 2021 with strong positive free cash flow.
  • Procaps has a direct presence in 13 countries in Latin America and has more than 5,000 collaborators working under a sustainable model.
  • Procaps develops, manufactures, and markets over-the-counter (OTC) and prescription drugs, nutritional supplements and high-potency clinical solutions.
  • A number of factors could cause actual results or outcomes to differ materially from those indicated by such forward-looking statements.

Capital Rx and 3 Axis Advisors Study Finds Potential for Billions in Prescription Drug Savings With Transparent Pricing Practices

Retrieved on: 
Tuesday, May 11, 2021

The full study results are available here .\nPotential legislative changes could expand pharmacies\xe2\x80\x99 retail survey reporting of NADAC.

Key Points: 
  • The full study results are available here .\nPotential legislative changes could expand pharmacies\xe2\x80\x99 retail survey reporting of NADAC.
  • Utilizing NADAC is free on a public website, increasing transparency and visibility into actual average retail drug acquisition price.\nMatthew Gibbs, Pharm.
  • D., President of Commercial Markets at Capital Rx, said, \xe2\x80\x9cThis study clearly shows that greater transparency with prescription drug pricing practices could create billions of dollars in savings for patients and payers.
  • Capital Rx has been utilizing NADAC pricing as a foundation for our Clearinghouse Model for over three years.

Rx Savings Solutions Introduces AdminRx For Care Coordination

Retrieved on: 
Thursday, May 6, 2021

This results in increased time on the phone, manual entry errors and delays in member outreach.

Key Points: 
  • This results in increased time on the phone, manual entry errors and delays in member outreach.
  • "\nRx Savings Solutions offers an innovative, patented engagement software system empowering employers and employees to be educated consumers of healthcare.
  • Serving more than 9 million members nationwide, including 41 Fortune 500 clients and more than a dozen health plans, Rx Savings Solutions provides a state-of-the-art approach to pharmacy transparency using objective and unbiased information to inform better decision making.
  • Rx Savings Solutions was founded and is operated by a team of pharmacists and software engineers who support a collaborative, cost-saving solution for purchasing prescription drugs.

Biofrontera reports preliminary revenue for the month of April 2021

Retrieved on: 
Thursday, May 6, 2021

Ameluz\xc2\xae has been marketed in the EU since 2012 and in the United States since May 2016.

Key Points: 
  • Ameluz\xc2\xae has been marketed in the EU since 2012 and in the United States since May 2016.
  • In addition, the company markets the prescription medication Xepi\xc2\xae for the treatment of impetigo in the United States.
  • Given these risks, uncertainties and other factors, prospective investors are cautioned not to place undue reliance on these forward-looking statements.
  • The Company does not undertake an obligation to update or revise any forward-looking statement.\n'

Large Study Analyzes Two Different Classes of ADHD Drugs in Preschool-Age Children

Retrieved on: 
Tuesday, May 4, 2021

The researchers found that both classes of drugs have benefits, with differing side effects, suggesting that decisions on which class of drugs to prescribe should be made based on individual patient factors.

Key Points: 
  • The researchers found that both classes of drugs have benefits, with differing side effects, suggesting that decisions on which class of drugs to prescribe should be made based on individual patient factors.
  • In contrast, children aged 5 to younger than 6 prescribed were likely to continue using the medication for longer if they were prescribed a stimulant.
  • "Future research should seek to learn more about the use of these classes of drugs in preschool-age children so that we can prescribe the most effective therapy for each patient.
  • In addition, its unique family-centered care and public service programs have brought the 595-bed hospital recognition as a leading advocate for children and adolescents.

LifeMD to Release First Quarter 2021 Financial Results on Thursday, May 13, 2021

Retrieved on: 
Tuesday, May 4, 2021

LifeMD\'s telemedicine platform enables virtual access to affordable and convenient medical treatment from licensed providers and, when appropriate, prescription medications and over-the-counter products delivered directly to the patient\'s home.

Key Points: 
  • LifeMD\'s telemedicine platform enables virtual access to affordable and convenient medical treatment from licensed providers and, when appropriate, prescription medications and over-the-counter products delivered directly to the patient\'s home.
  • Forward-looking statements are inherently subject to risks, uncertainties and assumptions.
  • Many of the forward-looking statements contained in this news release may be identified by the use of forward-looking words such as "believe," "expect," "anticipate," "should," "planned," "will," "may," "intend," "estimated," and "potential," among others.
  • All forward-looking statements attributable to LifeMD, Inc. or a person acting on its behalf are expressly qualified in their entirety by this cautionary language.\n'

Biofrontera AG: First quarter conference call to be held on May 12, 2021

Retrieved on: 
Monday, May 3, 2021

The company\xe2\x80\x99s lead product is the combination of Ameluz\xc2\xae, a topical prescription drug, and medical device BF-RhodoLED\xc2\xae for the photodynamic therapy of certain superficial skin cancers and their precursors.

Key Points: 
  • The company\xe2\x80\x99s lead product is the combination of Ameluz\xc2\xae, a topical prescription drug, and medical device BF-RhodoLED\xc2\xae for the photodynamic therapy of certain superficial skin cancers and their precursors.
  • Ameluz\xc2\xae has been marketed in the EU since 2012 and in the United States since May 2016.
  • In addition, the company markets the prescription medication Xepi\xc2\xae for the treatment of impetigo in the United States.
  • The Biofrontera Group was founded in 1997 by the current CEO Prof. Dr. Hermann L\xc3\xbcbbert and is listed on the Frankfurt Stock Exchange (Prime Standard) and on the US NASDAQ.

Oklahoma and Appriss Health Announce First Year Outcomes on Integration of Prescription Drug Monitoring Program Data into Providers' Electronic Workflows Advancing

Retrieved on: 
Wednesday, April 28, 2021

This integration is an essential component of our statewide strategy to reduce the misuse of prescription drugs in Oklahoma.

Key Points: 
  • This integration is an essential component of our statewide strategy to reduce the misuse of prescription drugs in Oklahoma.
  • "\nThe OBN is fully paying for the state\'s physicians to connect to the state\'s PMP database using Appriss Health\'s PMP Gateway solution for a minimum of two years.
  • Since 2020, there are 98 organizations, 1,110 facilities, and more than 8,000 prescribers integrated through PMP Gateway.
  • There were 197 drug overdose deaths that involved opioids in Oklahoma in 2019, of which 35% involved pharmaceutical opioids.

Lower Black Infant Mortality Rates in Los Angeles is Goal Of New Health Net-Funded Grant for Cherished Futures

Retrieved on: 
Thursday, April 22, 2021

Stakeholders included:\nThanks in part to this new funding, the Cherished Futures collaborative now moves forward in 2021 to implement a variety of systems-change strategies.

Key Points: 
  • Stakeholders included:\nThanks in part to this new funding, the Cherished Futures collaborative now moves forward in 2021 to implement a variety of systems-change strategies.
  • For more information about Cherished Futures, visit www.cherishedfutures.org .\nFor more news about Health Net, please visit www.HealthNet.com .
  • Health Net also offer access to substance abuse programs, behavioral health services, employee assistance programs and managed health care products related to prescription drugs.
  • We offer these health plans and services through Health Net, LLC and its subsidiaries: Health Net of California, Inc., Health Net Life Insurance Company and Health Net Community Solutions, Inc.

124 Patient Groups Urge Biden Administration to Improve Prescription Drug Affordability

Retrieved on: 
Friday, April 23, 2021

b'WASHINGTON, April 23, 2021 /PRNewswire/ -- The HIV+Hepatitis Policy Institute ( HIV+Hep ) and American Autoimmune Related Diseases Association ( AARDA ), in collaboration with 122 other patient and provider organizations, delivered a sign-on letter to U.S. Department of Health and Human Services (HHS) Secretary Xavier Becerra that urges HHS and the Biden administration to enact policies and protections that improve prescription drug affordability for the American people.

Key Points: 
  • b'WASHINGTON, April 23, 2021 /PRNewswire/ -- The HIV+Hepatitis Policy Institute ( HIV+Hep ) and American Autoimmune Related Diseases Association ( AARDA ), in collaboration with 122 other patient and provider organizations, delivered a sign-on letter to U.S. Department of Health and Human Services (HHS) Secretary Xavier Becerra that urges HHS and the Biden administration to enact policies and protections that improve prescription drug affordability for the American people.
  • The letter details how recent trends in the healthcare system, including high deductible plans and high cost-sharing, have threatened treatment affordability for patients, which negatively impacts adherence and worsens health outcomes.
  • The patient advocates encourage Secretary Becerra and the Biden administration to:\nInstitute Cost-Sharing Caps for Patients.\nRequire Insurers to Offer Plans that Include First Dollar Coverage of Prescription Drugs.\nCount Copay Assistance Towards Patient\'s Out-Of-Pocket Maximums.\nAddress the Role of Rebates and Pharmacy Benefit Managers.\n"While the Biden administration and Congress have recently taken steps to make insurance premiums more affordable, they must also enact policies to ensure insurance works for patients by improving prescription drug affordability.
  • "We look forward to working with Secretary Becerra and President Biden to implement solutions that improve prescription drug affordability and access for the American people and build on the foundation of the Affordable Care Act.